These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16314623)

  • 21. Timing of critical genetic changes in human breast disease.
    Ellsworth RE; Ellsworth DL; Deyarmin B; Hoffman LR; Love B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2005 Dec; 12(12):1054-60. PubMed ID: 16228814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
    Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
    Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
    Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
    Selim AG; Ryan A; El-Ayat G; Wells CA
    J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer].
    Romanowicz-Makowska H; Smolarz B
    Pol Merkur Lekarski; 2006 Dec; 21(126):548-50. PubMed ID: 17405295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
    Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
    Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
    Bean GR; Ibarra Drendall C; Goldenberg VK; Baker JC; Troch MM; Paisie C; Wilke LG; Yee L; Marcom PK; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Scott V; Seewaldt VL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):50-6. PubMed ID: 17220331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terminal duct lobular units are scarce in the nipple: implications for prophylactic nipple-sparing mastectomy: terminal duct lobular units in the nipple.
    Stolier AJ; Wang J
    Ann Surg Oncol; 2008 Feb; 15(2):438-42. PubMed ID: 18004629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
    King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
    Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
    Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.
    Farshid G; Balleine RL; Cummings M; Waring P;
    Am J Surg Pathol; 2006 Nov; 30(11):1357-66. PubMed ID: 17063074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 mutations and prostate cancer in Poland.
    Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
    Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.
    Zubor P; Lasabova Z; Hatok J; Stanclova A; Danko J
    Oncol Rep; 2007 Jul; 18(1):211-7. PubMed ID: 17549370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study.
    Kotsopoulos J; Sukiennicki G; Muszyńska M; Gackowski D; Kąklewski K; Durda K; Jaworska K; Huzarski T; Gronwald J; Byrski T; Ashuryk O; Dębniak T; Tołoczko-Grabarek A; Stawicka M; Godlewski D; Oliński R; Jakubowska A; Narod SA; Lubinski J
    Cancer Causes Control; 2012 Jul; 23(7):1065-74. PubMed ID: 22576580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients.
    Li Z; Moore DH; Meng ZH; Ljung BM; Gray JW; Dairkee SH
    Cancer Res; 2002 Feb; 62(4):1000-3. PubMed ID: 11861372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.
    Tripathi A; King C; de la Morenas A; Perry VK; Burke B; Antoine GA; Hirsch EF; Kavanah M; Mendez J; Stone M; Gerry NP; Lenburg ME; Rosenberg CL
    Int J Cancer; 2008 Apr; 122(7):1557-66. PubMed ID: 18058819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.